A detailed history of State Of Wyoming transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, State Of Wyoming holds 18,749 shares of PSTX stock, worth $177,928. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,749
Holding current value
$177,928
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.7 - $4.04 $50,622 - $75,745
18,749 New
18,749 $53,000
Q4 2022

Feb 14, 2023

BUY
$3.33 - $6.38 $23,796 - $45,591
7,146 New
7,146 $37,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $814M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.